Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Trends in Pharmacological Sciences
|
February 21, 2024
Histone lysine acetyltransferase inhibitors: an emerging class of drugs for cancer therapy
Jeffrey White, Frederick A Derheimer, Kristen Jensen-Pergakes, et al.
Epigenetics & Chromatin
|
January 31, 2012
Lysine methyltransferase G9a is not required for DNMT3A/3B anchoring to methylated nucleosomes and maintenance of DNA methylation in somatic cells
Shikhar Sharma, Daniel S Gerke, Han F Han, et al.
Advances in Therapy
|
May 24, 2020
The Promise for Histone Methyltransferase Inhibitors for Epigenetic Therapy in Clinical Oncology: A Narrative Review
Hope S Rugo, Ira Jacobs, Shikhar Sharma, et al.
Molecular Oncology
|
October 20, 2021
Intrinsic and acquired drug resistance to LSD1 inhibitors in small cell lung cancer occurs through a TEAD4-driven transcriptional state
Wen Yan, Chi-Yeh Chung, Tao Xie, et al.
Plos Genetics
|
April 28, 2010
Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer
Erika M Wolff, Hyang-Min Byun, Han F Han, et al.
Molecular and Cellular Biology
|
July 22, 2009
Selective anchoring of DNA methyltransferases 3A and 3B to nucleosomes containing methylated DNA
Shinwu Jeong, Gangning Liang, Shikhar Sharma, et al.
Cancer Cell
|
May 26, 2012
DNA methylation screening identifies driver epigenetic events of cancer cell survival
Daniel D De Carvalho, Shikhar Sharma, Jueng Soo You, et al.
Nucleic Acids Research
|
July 17, 2008
DNA methylation analysis by digital bisulfite genomic sequencing and digital MethyLight
Daniel J Weisenberger, Binh N Trinh, Mihaela Campan, et al.
Cancer Letters
|
November 7, 2022
ENT1 blockade by CNX-774 overcomes resistance to DHODH inhibition in pancreatic cancer
Nicholas J Mullen, Ravi Thakur, Surendra K Shukla, et al.
Cancer Research
|
July 4, 2015
The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies
Bhavatarini Vangamudi, Thomas A Paul, Parantu K Shah, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Trends in Pharmacological Sciences
|
February 21, 2024
Histone lysine acetyltransferase inhibitors: an emerging class of drugs for cancer therapy
Jeffrey White, Frederick A Derheimer, Kristen Jensen-Pergakes, et al.
Epigenetics & Chromatin
|
January 31, 2012
Lysine methyltransferase G9a is not required for DNMT3A/3B anchoring to methylated nucleosomes and maintenance of DNA methylation in somatic cells
Shikhar Sharma, Daniel S Gerke, Han F Han, et al.
Advances in Therapy
|
May 24, 2020
The Promise for Histone Methyltransferase Inhibitors for Epigenetic Therapy in Clinical Oncology: A Narrative Review
Hope S Rugo, Ira Jacobs, Shikhar Sharma, et al.
Molecular Oncology
|
October 20, 2021
Intrinsic and acquired drug resistance to LSD1 inhibitors in small cell lung cancer occurs through a TEAD4-driven transcriptional state
Wen Yan, Chi-Yeh Chung, Tao Xie, et al.
Plos Genetics
|
April 28, 2010
Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer
Erika M Wolff, Hyang-Min Byun, Han F Han, et al.
Molecular and Cellular Biology
|
July 22, 2009
Selective anchoring of DNA methyltransferases 3A and 3B to nucleosomes containing methylated DNA
Shinwu Jeong, Gangning Liang, Shikhar Sharma, et al.
Cancer Cell
|
May 26, 2012
DNA methylation screening identifies driver epigenetic events of cancer cell survival
Daniel D De Carvalho, Shikhar Sharma, Jueng Soo You, et al.
Nucleic Acids Research
|
July 17, 2008
DNA methylation analysis by digital bisulfite genomic sequencing and digital MethyLight
Daniel J Weisenberger, Binh N Trinh, Mihaela Campan, et al.
Cancer Letters
|
November 7, 2022
ENT1 blockade by CNX-774 overcomes resistance to DHODH inhibition in pancreatic cancer
Nicholas J Mullen, Ravi Thakur, Surendra K Shukla, et al.
Cancer Research
|
July 4, 2015
The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies
Bhavatarini Vangamudi, Thomas A Paul, Parantu K Shah, et al.
Page
of 3